Skip to main content

AlgoSurg

SoftwareWilmington, Delaware, United StatesFounded 2018· One of 362 Software companies tracked by AMPulse

AI-powered surgical planning platform for implant OEMs, robotic surgery, navigation/AR systems, and 3D printing providers

CEO / Founder
Dr. Vikas Karade
Team Size
1-10
Stage
Seed
Total Funding
$125K
Latest Round
Seed
Key Investors
Y Combinator; Plug and Play Tech Center; SINE (IIT Bombay); Intuitive Foundation; Department of Science and Technology, Government of India

Technology & Products

Key Products

AI Surgical Planning Platform (white-label for OEMs); Robotic TKR/THR AI Planning; Automated 3D Planning for Structural Heart Surgery (TAVR); DeftFix (FDA-approved cloud planner for hexapod fixators); AI-Driven CMF Surgery Planning & 3D Printing; AI-Powered CT-MRI Fusion & Resection Planning for Bone Tumors; Tabplan3D (3D planning for complex orthopedic deformities); OpenSurgiSim (cloud + AR training for surgeons)

Technological Advantage

Proprietary AI models based on enhanced nnU-Net architecture with shape-constrained statistical models; cloud-based platform with API integration; proven commercial deployments with leading MedTech OEMs (Meril MISSO robotic system, SH Pitkar DeftFix); Y-Combinator and Plug-and-Play backed; FDA submission in progress for multiple products

Differentiation

Value Proposition

End-to-end AI platform that automates surgical planning from CT/MRI scans to 3D models, surgical plans, and custom patient-specific instruments — reducing planning time from hours to minutes with 10x faster workflows

How They Differentiate

Unlike competitors that solve only part of the surgical planning pipeline, AlgoSurg delivers a complete end-to-end solution from image segmentation to 3D modeling, landmark identification, and surgical tool design — optimized for both robotic surgery and 3D printing, with white-label/B2B licensing to MedTech OEMs rather than selling directly to hospitals

Market & Competition

Target Customers

MedTech implant OEMs, robotic surgery system manufacturers, navigation/AR-VR system providers, and 3D printing companies (white-label/B2B licensing)

Industry Verticals

Orthopedic surgery (joint replacement, deformity correction, trauma); Cardiovascular surgery (TAVR); Maxillofacial (CMF) surgery; Oncologic orthopedic surgery; Surgical training and education

Competitors

PeekMed; Lazarus 3D; Insight Surgery; Biomodex; Mirrakoi

Growth & Milestones

Growth Metrics

15,000+ surgeries powered; 500+ surgeons served; 200+ surgical robots using AlgoSurg AI; 10x faster surgery planning; 5+ surgical applications; 100+ deployed systems globally

Major Milestones

2018: Founded, Y Combinator W18 batch; 2018: Seed funding from Y Combinator; 2021: OpenSurgiSim funded by Intuitive Foundation; 2024: AI planning licensed by Meril for MISSO robotic system (EU-MDR Approved); DeftFix receives FDA approval; 2025: 15,000+ surgeries powered; US-FDA submission in progress for robotic TKR/THR and TAVR planning

Notable Customers

Meril Healthcare (MISSO robotic joint replacement system); SH Pitkar Orthotools (DeftFix hexapod fixator planner); Leading global TAVR implant OEM (structural heart planning)

Recent coverage of AlgoSurg